Company / Capital Expenditures
Zoetis Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$621.0M
FY2025
5-year range
$453.0M / $655.0M
FY2021-FY2025
Trend
-5.2%
vs FY2024
Sector context
#8 of 194
Health Care
What the data says
Among 194 Health Care companies, Zoetis is in the top 4% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $180M in FY2016 to $655M in FY2024.
Based on SEC 10-K filings.
$621M in FY2025 with a 5-year CAGR of +12.9%. Top quartile in the Health Care sector.
Improved from $477M to $621M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- +12.9%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 194This company $621.0M Sector average $117.5M
▼
+428.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +12.9%, indicating consistent growth.
- In FY2025, capital expenditures decreased 5.2% year-over-year.
- Ranks #8 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $621.0M | -5.2% |
| FY2024 | $655.0M | +37.3% |
| FY2023 | $477.0M | +5.3% |
| FY2022 | $453.0M | -1.5% |
| FY2021 | $460.0M | +36.1% |
| FY2020 | $338.0M | -26.5% |
| FY2019 | $460.0M | +36.1% |
| FY2018 | $338.0M | +50.9% |
| FY2017 | $224.0M | +24.4% |
| FY2016 | $180.0M | -2.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026